This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

A.D.A.M.'s SmartEngage Wins Top Digital Marketing Award At 4th Annual Digital Marketing Canada Summit

ATLANTA, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Ebix, Inc. (Nasdaq:EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance industry, announced that the Company's A.D.A.M. SmartEngageā„¢ product recently won Best Unbranded Consumer Website/Microsite at the 4 th Annual Digital Marketing Canada Summit October 28-29, 2013 at the West Prince Toronto. Presented by eyeforpharma, Digital Marketing Canada brings together an influential audience of healthcare industry leaders for educational sessions and networking.

SmartEngage is a comprehensive consumer healthcare education tool that includes a multimedia encyclopedia, in-depth reports, complementary and alternative medicine, wellness tools, health navigator and the A.D.A.M. community.

Vice President of A.D.A.M. Soula Chronopoulos said, "The SmartEngage program was designed to provide comprehensive patient education that not only connects the end user to the healthcare organization, but also empowers the patient to take control of their health. Mobile enabled and enhanced with award-winning images and animations, the program engages and informs the user on critical self-care topics, and promotes compliance and patient outreach."

The product is flexible in allowing healthcare organizations to embed the content within their consumer and patient portals, with the ability to customize the content to meet their specific goals.

Soula Chronopoulos added, "Enabling this feature gives the healthcare organization complete ownership of the articles, yet the organization will continue to receive regular medical updates from A.D.A.M. Furthermore, we are evolving the program to support patient journeys that tap into gamification that will provide patients with key information that will help them make informed decisions about their health."

The content is available in English, Portuguese, and Spanish.

In summary this "Next Generation" tool from A.D.A.M. makes complex healthcare subject matter understandable and most importantly usable by the patient so that they really can participate in managing their own health!

About eyeforpharma:

eyeforpharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content. Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals can offer. We actively respond to the aims and interests of our audience, so please get in touch if you think we can do even more. eyeforpharma is part of FC Business Intelligence Ltd. FC Business Intelligence Ltd is a registered company in England and Wales - Registered number 04388971, 7-9 Fashion Street, London, E1 6PX, UK.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 1.64%
FB $117.43 -0.96%
GOOG $692.36 -0.84%
TSLA $232.32 -3.92%
YHOO $36.01 -1.42%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs